Young patients with gastric cancer (<40 years) often harbor unique molecular characteristics, including a higher prevalence of genomic instability (e.g., TP53 mutations and ARID1A loss) and epigenetic abnormalities (17). This evidence concerns the gene ARID1A and gastric cancer.